HDFC LIFE INSURANCE COMPANY rallied up from 457.8 to 690.85 in a wave 1 structure beginning in march 2023 ending in July.2023.
However from July the stock got into a wave 2 correction and seems to have ended the very same in Oct. end.
The stock ended the wave 2 correction(technically a "flat" according to Elliot wave theory) at a very crucial support/resistance zone of 600 that is relevant since May.2022.
Coming to the very recent price action of the stock, the stock traded in a very narrow range for 7 days(613-626)between 1st Nov. till 9th Nov. and is now looking to break out of this range.(Generally referred to as NR7 breakout.)
The 600 level has worked as a very good support for the stock and therefore SL can be placed below it at 595-597 to try and catch the new upcoming wave that can give 40% returns going forward into 2024.
Note*- kindly try to understand the business model and key fundamentals of a company before making any investing decisions.
However from July the stock got into a wave 2 correction and seems to have ended the very same in Oct. end.
The stock ended the wave 2 correction(technically a "flat" according to Elliot wave theory) at a very crucial support/resistance zone of 600 that is relevant since May.2022.
Coming to the very recent price action of the stock, the stock traded in a very narrow range for 7 days(613-626)between 1st Nov. till 9th Nov. and is now looking to break out of this range.(Generally referred to as NR7 breakout.)
The 600 level has worked as a very good support for the stock and therefore SL can be placed below it at 595-597 to try and catch the new upcoming wave that can give 40% returns going forward into 2024.
Note*- kindly try to understand the business model and key fundamentals of a company before making any investing decisions.
Investors should remain cautious about this latest piece of information and are advised not to participate in the stock till the air around this news settles.
Remember if you miss out on one you will always find another. Do not get stuck with stocks that come with controversies and allegations.